GB2041763A - An inhalor for pulverulent medicinal substances - Google Patents
An inhalor for pulverulent medicinal substances Download PDFInfo
- Publication number
- GB2041763A GB2041763A GB8003168A GB8003168A GB2041763A GB 2041763 A GB2041763 A GB 2041763A GB 8003168 A GB8003168 A GB 8003168A GB 8003168 A GB8003168 A GB 8003168A GB 2041763 A GB2041763 A GB 2041763A
- Authority
- GB
- United Kingdom
- Prior art keywords
- nozzle
- dosing
- chamber
- inhalator
- cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Nozzles (AREA)
Abstract
The inhalor for pulverulent medicinal substances combining the function of a dosage feeder comprises a nozzle 1, a chamber 8 for the storage of the medicinal substance which can rotate relatively to the nozzle 1, and a cavity 18, for the collection of successive doses of the medicinal substance, communicating with the nozzle 1. Dosing means 14, 14', 15 are provided on the bottom 10 of the chamber 8 and co-operate with dispensing means 16, 17 operated by the relative rotation between the chamber 8 and the nozzle 1 to pour individual and successive doses of medicinal substance into the cavity 18, for inhaling through the nozzle 1. <IMAGE>
Description
SPECIFICATION
An inhalator for medicinal substances
This invention relates to an inhalator for pulverulent medicinal substances combining the function of a dosage feeder.
The application of medicinal substances in the form of powders by inhalation is quite important in the treatment of pathological forms. To this end, several types of inhalators are already known for inhalation of powders obtained by breakage of capsules and devices for inhalation of pulverulent medicinal substances are known as well.
However, it was found that this second type of apparatus does not provide the desired results due to the particular structure thereof, difficulty in use and not always providing the current dosage.
It is the object of the present invention to provide an inhalator for pulverulent medicinal substances, which avoids the drawbacks found in conventional devices of this type.
This and further objects of the invention will become apparent to those skilled in the art when considering the following description and claims.
According to our invention an inhalator for pulverulent medicinal substances combining the function of a dosage feeder comprises a nozzle, a chamber for storing the said medicinal substance which can rotate relative to said nozzle, a cavity for the collection of successive doses of said medicinal substance communicating with said nozzle, dosing means for said substance provided on the bottom of said chamber, and dispensing means controlled by said relative rotation between said chamber and nozzle to pour into said cavity individual and successive doses of the medicinal substance withdrawn by said dosing means.
A preferred embodiment of the invention is shown only by way of unrestrictive example in the figures of the accompanying drawings, in which:
Figure 1 is a side view of the inhalator as a who!e;
Figure 2 is an enlarged sectional view taken along line Il-Il of Figure 1;
Figure 3 is an enlarged view according to arrow
A of Figure 1;
Figure 4 is a sectional view taken along line lV-IV of Figure 2;
Figure 5 is a sectional view taken along line V-V of Figure 2; and
Figure 6 is an enlarged view according to arrow
B of Figure 1.
Referring to the above Figures of the accompanying drawings, the inhalator essentially comprises a nozzle generally designated at 1 which is mounted for free rotation on a main body generally designated at 2.
The nozzle 1 has an opening 3 communicating with an inner space 4 which tapers to a circular hole 5 leading, in turn, to a central conduit 6 which slightly tapers in the opposite direction which respect to the hole 5. The conduit 6 comprises a tubular element 7 arranged axially of the body and free to rotate with respect to the latter. The element 7 is integral with a crown 5' which forms part of the nozzle 1 and defines the hole 5.
The body 2 defines a storage chamber 8 for a pulverulent medicinal substance and advantageously the volume of such a chamber is such as to store an amount of medicinal substance sufficient for a complete treatment cycle. A closure element 9 defines the top of chamber 8, whereas the lower part thereof is defined by a bottom 10 connecting to the wall 11 of chamber 8 through an inclined surface 12 forming with the bottom 10 an annular vertical surface 13.
Two opposing dosing holes 14 and 14' are formed in the bottom 10, each of which has a volume exactly corresponding to one dose of medicament.
At the bottom side the end portion of the tubular element 7 has an integral diaphragm or skirt 15, which is semi-circular and horizontal and bears on the annular surface 13. The skirt is discontinuous for some length substantially corresponding to the length of each of the dosing holes 14, 14' (Figure 4).
The extreme portion of the element 7 has keyed thereto at the bottom of said bottom 10 at 16' a dispensing disc 16 which is provided with a dispensing hole 17 intended for successive registration with the dosing holes 14 and 14', as described in the following.
The lower portion of the body 2 forms a cavity 1 8 communicating with the exterior of the nozzle by two labyrinth-shaped opposing apertures 19 (Figure 6), such a shape being due to the provision of tortous walls 20.
Substantially at the level of the skirt 1 5 and internally of the conduit 6, element 7 is provided with helically extending blades 21. At the level of the dispensing disc 1 6 internally of the body 2 two opposing projections 22 and 22' are provided and are intended to be successively engaged by two tongues 23 formed on the peripheral edge of the dosing disc 16 opposite to the dispensing hole 1 7.
Should the inhalator be of a disposal type, means must be made for breaking the seal when the inhalator is first to be used. These means comprises a breakable small pin 24 which is integral with the body 2. Upon first filling and assembling the inhalator the pin 24 engages in a notch formed peripherally in the dosing disc 16, or also equivalent means located between the nozzle 1 and the body 2.
Prior to initial use, as shown in the Figures of the drawings, the chamber 8 is filled with a sufficient amount of medicament for a complete treatment cycle, the skirt 15 closes the dosing and dispensing holes 140 and 17, now in register, the dosing hole 14 is full with a dose of medicament in register with the discontinuous zone of the skirt 15 and is closed at the bottom by the dispensing disc 16, the small integral pin 24 engages the notch 25 to ensure the integrity of the inhalator, and the tongue 23 engage the notch 22'.
In operation, a user causes relative rotation between the nozzle 1 and the body 2 to take place by gripping the inhalator with one hand at one region 26 of knurling and by the other hand at another level of the knurling 26', so as to rotate the dispensing disc 16 through 1800. This results in breakage of the small pin 24 until further rotation is prevented by engagement of the tongues 23 with the notch 22.
During such a rotation, the dispensing hole 17 is moved into register with the dosing hole 14 and the dose stored in the latter is pored into the cavity 18, from which it can be inhaled through the conduit 6 and the nozzle 1, owing to the air inflow within the chamber 18 through the labyrinth apertures 19 and also owing to the turbulent motion imparted to the medicament by the helical blades 21. During this rotation, said skirt 15 exposes the dosing hole 14', now closed at the bottom by the dispensing disc 1 6, which will thus be filled up with a new dose in readiness for next use.
Claims (10)
1. An inhalator for pulverulent medicinal
substances combining the function of a dosage feeder, comprising a nozzle, a storage chamber for
said medicinal substance and rotatable relative to
said nozzle, a cavity for the collection of
successive doses of said medicinal substance
communicating with said nozzle, dosing means
formed on the bottom of said chamber, and
dispensing means controlled by said relative
rotation between said chamber and said nozzle to
pour into said cavity individual and successive
doses of the medicinal substance as withdrawn by
said dosing means.
2. An inhalator according to Claim 1, in which
said dosing means comprise at least one dosing
hole formed on the bottom of said storage
chamber, and a diaphragm for communication
during said relative rotation said chamber with
said at least one dosing hole.
3. An inhalator according to Claim 2, in which said dispensing means comprise a disc provided with at least one dispensing hole communicating with said cavity for registration during said relative rotation with said at least one dosing hole to pour the dose stored therein into said cavity.
4. An inhalator according to Claim 3, in which the nozzle communicates with said cavity through a conduit carrying said diaphragm and said dosing disc, said nozzle being integral with said conduit, whereby a relative rotation between said nozzle and said chamber causes a corresponding relative rotation between said conduit and the bottom of said chamber.
5. An inhalator according to Claim 4, in which said diaphragm rests with its underside on the upper side of the bottom and the disc rests with its upper side on the underside of said bottom.
6. An inhalator according to Claim 1, in which means are provided for indicating the registering position between said dosing and dispensing means.
7. An inhalator according to Claim 1, in which said storage chamber contains an amount of medicinal substance corresponding to the total amount required for a complete treatment cycle, the dispensing capacity of individual dosing means being calculated in accordance with the nature of said medicinal substance.
8. An inhalator according to Claim 7, in which means are provided as a guarantee to be broken upon the first use of said inhalator.
9. An inhalator according to Claim 1, in which said cavity is formed on and opposite to the bottom of said chamber and has labyrinth apertures communicating with the outside, helical blade-shaped means being interposed between said cavity and said nozzle.
10. An inhalator substantially as described herein with reference to and as illustrated in the accompanying drawings.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2068879U IT7920688V0 (en) | 1979-02-05 | 1979-02-05 | INHALER FOR PULVERULENT MEDICINAL SUBSTANCES, WITH COMBINED DOSER FUNCTION. |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2041763A true GB2041763A (en) | 1980-09-17 |
GB2041763B GB2041763B (en) | 1983-08-17 |
Family
ID=11170583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8003168A Expired GB2041763B (en) | 1979-02-05 | 1980-01-30 | Inhalor for pulverulent medicinal substances |
Country Status (5)
Country | Link |
---|---|
DE (1) | DE8002702U1 (en) |
ES (1) | ES248348Y (en) |
FR (1) | FR2447725A3 (en) |
GB (1) | GB2041763B (en) |
IT (1) | IT7920688V0 (en) |
Cited By (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0069715A1 (en) * | 1981-07-08 | 1983-01-12 | Aktiebolaget Draco | Powder inhalator |
GB2144997A (en) * | 1981-07-08 | 1985-03-20 | Draco Ab | Dosage inhalator |
US4570630A (en) * | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
GB2165159A (en) * | 1984-10-04 | 1986-04-09 | Orion Yhtymae Oy | Dosing device |
WO1991012040A1 (en) * | 1990-02-16 | 1991-08-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Powder inhalator |
DE4106379A1 (en) * | 1990-03-02 | 1991-09-05 | Glaxo Group Ltd | INHALATION DEVICE AND PACKAGE FOR THIS |
US5046493A (en) * | 1988-02-16 | 1991-09-10 | James Kropkowski | Nasal dispenser |
WO1991013646A1 (en) * | 1990-03-07 | 1991-09-19 | Fisons Plc | Medicament inhalation device |
EP0451745A1 (en) * | 1990-04-12 | 1991-10-16 | CHIESI FARMACEUTICI S.p.A. | Device for the administration of powdered medicinal substances |
EP0518087A1 (en) * | 1991-06-14 | 1992-12-16 | Miat S.P.A. | Multi-dose insufflator for medicaments in powder form |
US5176132A (en) * | 1989-05-31 | 1993-01-05 | Fisons Plc | Medicament inhalation device and formulation |
WO1993009832A1 (en) * | 1991-11-12 | 1993-05-27 | Minnesota Mining And Manufacturing Company | Inhalation device |
US5243970A (en) * | 1991-04-15 | 1993-09-14 | Schering Corporation | Dosing device for administering metered amounts of powdered medicaments to patients |
WO1993021980A1 (en) * | 1992-05-05 | 1993-11-11 | Astra Aktiebolag | Dosage inhalator with indicating/interrupting means |
EP0573128A2 (en) * | 1990-07-13 | 1993-12-08 | Innovata Biomed Limited | Inhaler |
US5301666A (en) * | 1991-12-14 | 1994-04-12 | Asta Medica Aktiengesellschaft | Powder inhaler |
US5394868A (en) * | 1992-06-25 | 1995-03-07 | Schering Corporation | Inhalation device for powdered medicaments |
US5437271A (en) * | 1993-04-06 | 1995-08-01 | Minnesota Mining And Manufacturing Company | Deagglomerators for dry powder inhalers |
US5441060A (en) * | 1993-02-08 | 1995-08-15 | Duke University | Dry powder delivery system |
US5447151A (en) * | 1990-10-04 | 1995-09-05 | Valois | Powder inhaler with suction actuated locking means |
WO1995029723A1 (en) * | 1994-05-03 | 1995-11-09 | Transcoject Marketing Gmbh | Inhaler |
US5469843A (en) * | 1991-11-12 | 1995-11-28 | Minnesota Mining And Manufacturing Company | Inhalation device |
US5533502A (en) * | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US5615670A (en) * | 1990-03-07 | 1997-04-01 | Fisons Plc | Powder inhaler with centrifugal force used to meter powder |
US5687710A (en) * | 1992-12-18 | 1997-11-18 | Schering Corporation | Inhaler for powdered medications having spiral deagglomeration chamber |
US5975076A (en) * | 1993-12-31 | 1999-11-02 | King's College London | Dry powder inhalers |
EP1291031A1 (en) * | 2000-06-12 | 2003-03-12 | Teijin Limited | Powder medicine multiple dose administration device |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
US7207330B1 (en) | 1999-06-05 | 2007-04-24 | Innovata Biomed Limited | Delivery system |
US7219665B1 (en) | 1999-09-04 | 2007-05-22 | Innovata Biomed Limited | Delivery device |
EP1283036B1 (en) * | 1998-11-13 | 2008-01-02 | Jagotec AG | Multidosis dry powder inhaler with powder reservoir |
EP1891974A1 (en) | 2004-05-31 | 2008-02-27 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and PDE4 inhibitors |
EP1891973A1 (en) | 2004-05-31 | 2008-02-27 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and PDE4 inhibitors |
EP1941868A2 (en) | 2000-02-28 | 2008-07-09 | PharmaKodex Limited | Improvements in or relating to the delivery of oral drugs |
WO2008107125A1 (en) | 2007-03-02 | 2008-09-12 | Almirall, S.A. | New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives |
US7464704B2 (en) | 2001-11-23 | 2008-12-16 | Innovata Biomed Limited | Medicament delivery assembly |
EP2096105A1 (en) | 2008-02-28 | 2009-09-02 | Laboratorios Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2108641A1 (en) | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
EP2113503A1 (en) | 2008-04-28 | 2009-11-04 | Laboratorios Almirall, S.A. | New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors |
US7617822B2 (en) | 2003-06-16 | 2009-11-17 | Rijksuniversiteit Groningen | Dry powder inhaler and method for pulmonary inhalation of dry powder |
EP2196465A1 (en) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors |
WO2010072354A1 (en) | 2008-12-22 | 2010-07-01 | Almirall, S.A. | MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR |
EP2221297A1 (en) | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases |
EP2221055A1 (en) | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function |
WO2010097172A1 (en) | 2009-02-27 | 2010-09-02 | Almirall, S.A. | New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives |
EP2263998A1 (en) | 2005-05-20 | 2010-12-22 | Almirall S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
EP2322176A1 (en) | 2009-11-11 | 2011-05-18 | Almirall, S.A. | New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives |
EP2380890A1 (en) | 2010-04-23 | 2011-10-26 | Almirall, S.A. | New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors |
EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
EP2394998A1 (en) | 2010-05-31 | 2011-12-14 | Almirall, S.A. | 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors |
WO2012041476A1 (en) | 2010-09-30 | 2012-04-05 | Almirall, S.A. | Pyridine and isoquinoline derivatives as syk- and jak-kinase inhibitors |
US8178679B2 (en) | 2007-11-28 | 2012-05-15 | Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors |
EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
WO2012069202A1 (en) | 2010-11-26 | 2012-05-31 | Almirall,S.A. | Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors |
EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
US8283342B2 (en) | 2007-02-09 | 2012-10-09 | Almirall S.A. | Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor |
EP2518070A1 (en) | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Pyrrolotriazinone derivatives as PI3K inhibitors |
EP2518071A1 (en) | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Imidazopyridine derivatives as PI3K inhibitors |
EP2527344A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
EP2526945A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | New CRTH2 Antagonists |
EP2548863A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists. |
EP2548876A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists |
EP2554544A1 (en) | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
EP2592077A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
US8511302B2 (en) | 2004-04-24 | 2013-08-20 | Innovata Biomed Limited | Dose counter mechanisms for medicament delivery devices |
US8524908B2 (en) | 2009-03-12 | 2013-09-03 | Almirall, S.A. | Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
EP2647627A1 (en) | 2012-04-02 | 2013-10-09 | Almirall, S.A. | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one. |
EP2666465A1 (en) | 2012-05-25 | 2013-11-27 | Almirall, S.A. | Novel dosage and formulation |
EP2668941A1 (en) | 2012-05-31 | 2013-12-04 | Almirall, S.A. | Novel dosage form and formulation of abediterol |
WO2014060431A1 (en) | 2012-10-16 | 2014-04-24 | Almirall, S.A. | Pyrrolotriazinone derivatives as pi3k inhibitors |
EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
WO2014095920A1 (en) | 2012-12-18 | 2014-06-26 | Almirall, S.A. | New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity |
WO2014124757A1 (en) | 2013-02-15 | 2014-08-21 | Almirall, S.A. | Pyrrolotriazine derivatives as pi3k inhibitors |
US8851069B2 (en) | 2004-04-21 | 2014-10-07 | Innovata Biomed Limited | Inhaler |
EP2848615A1 (en) | 2013-07-03 | 2015-03-18 | Almirall, S.A. | New pyrazole derivatives as CRAC channel modulators |
WO2015091287A1 (en) | 2013-12-19 | 2015-06-25 | Almirall S.A. | Dosage formulation comprising salmeterol and fluticasone propionate |
US9108918B2 (en) | 2011-10-07 | 2015-08-18 | Almirall, S.A. | Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate |
WO2016170009A1 (en) | 2015-04-21 | 2016-10-27 | Almirall, S.A. | Amino-substituted heterocyclic derivatives as sodium channel inhibitors |
WO2016180753A1 (en) * | 2015-05-08 | 2016-11-17 | Iconovo Ab | Dry powder inhaler |
WO2016202800A1 (en) | 2015-06-16 | 2016-12-22 | Almirall, S.A. | Pyrrolotriazinone derivatives as pi3k inhibitors |
WO2017076990A1 (en) | 2015-11-05 | 2017-05-11 | Almirall, S.A. | Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide |
USRE46417E1 (en) | 1999-07-14 | 2017-05-30 | Almirall, S.A. | Quinuclidine derivatives and their use as muscarinic M3 receptor ligands |
US9737520B2 (en) | 2011-04-15 | 2017-08-22 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
WO2019030298A1 (en) | 2017-08-08 | 2019-02-14 | Almirall, S.A. | Novel compounds activating the nrf2 pathway |
WO2019066702A1 (en) | 2017-09-28 | 2019-04-04 | Iconovo Ab | A dry powder inhaler with means for enhancing dispersion |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
SK280968B6 (en) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Medicament pack for use in an inhalation device |
TW197380B (en) | 1990-03-02 | 1993-01-01 | Glaxo Group Ltd | |
YU48712B (en) * | 1991-06-26 | 1999-07-28 | Schering Corporation | Inhalataion device for powdered medicaments |
DE10129703A1 (en) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Atomizing system for a powder mixture and method for dry powder inhalers |
-
1979
- 1979-02-05 IT IT2068879U patent/IT7920688V0/en unknown
-
1980
- 1980-01-30 FR FR8002322A patent/FR2447725A3/en active Granted
- 1980-01-30 GB GB8003168A patent/GB2041763B/en not_active Expired
- 1980-02-02 DE DE19808002702 patent/DE8002702U1/en not_active Expired
- 1980-02-05 ES ES80248348U patent/ES248348Y/en not_active Expired
Cited By (160)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0069715A1 (en) * | 1981-07-08 | 1983-01-12 | Aktiebolaget Draco | Powder inhalator |
GB2144997A (en) * | 1981-07-08 | 1985-03-20 | Draco Ab | Dosage inhalator |
US4524769A (en) * | 1981-07-08 | 1985-06-25 | Aktiebolaget Draco | Dosage inhalator |
US4570630A (en) * | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
GB2165159A (en) * | 1984-10-04 | 1986-04-09 | Orion Yhtymae Oy | Dosing device |
DE3535561A1 (en) * | 1984-10-04 | 1986-05-22 | Orion-yhtymä Oy, Espoo | DEVICE FOR DISPENSING A MEDICAL SUBSTANCE |
US5046493A (en) * | 1988-02-16 | 1991-09-10 | James Kropkowski | Nasal dispenser |
US5628307A (en) * | 1989-05-31 | 1997-05-13 | Fisons Plc | Medicament inhalation device and formulation |
US5176132A (en) * | 1989-05-31 | 1993-01-05 | Fisons Plc | Medicament inhalation device and formulation |
US5538999A (en) * | 1989-05-31 | 1996-07-23 | Fisons Plc | Medicament inhalation device and formulation |
US5341800A (en) * | 1989-05-31 | 1994-08-30 | Fisons Plc | Medicament inhalation device and formulation |
US5320714A (en) * | 1990-02-16 | 1994-06-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Powder inhalator |
WO1991012040A1 (en) * | 1990-02-16 | 1991-08-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Powder inhalator |
DE4106379A1 (en) * | 1990-03-02 | 1991-09-05 | Glaxo Group Ltd | INHALATION DEVICE AND PACKAGE FOR THIS |
DE4106379C2 (en) * | 1990-03-02 | 1998-09-24 | Glaxo Group Ltd | Inhaler and medication pack therefor |
US6032666A (en) * | 1990-03-02 | 2000-03-07 | Glaxo Group Limited | Inhalation device |
WO1991013646A1 (en) * | 1990-03-07 | 1991-09-19 | Fisons Plc | Medicament inhalation device |
US5615670A (en) * | 1990-03-07 | 1997-04-01 | Fisons Plc | Powder inhaler with centrifugal force used to meter powder |
US5351683A (en) * | 1990-04-12 | 1994-10-04 | Chiesi Farmaceutici S.P.A. | Device for the administration of powdered medicinal substances |
EP0451745A1 (en) * | 1990-04-12 | 1991-10-16 | CHIESI FARMACEUTICI S.p.A. | Device for the administration of powdered medicinal substances |
EP0573128A3 (en) * | 1990-07-13 | 1994-03-02 | Innovata Biomed Ltd | |
EP0573128A2 (en) * | 1990-07-13 | 1993-12-08 | Innovata Biomed Limited | Inhaler |
US5437270A (en) * | 1990-07-13 | 1995-08-01 | Innovata Biomed Limited | Powder inhaler having a multi-positioned metering cup |
US5657748A (en) * | 1990-07-13 | 1997-08-19 | Innovata Biomed Limited | Powder inhaler with frusto-conical metering surface having dose indentations |
US5447151A (en) * | 1990-10-04 | 1995-09-05 | Valois | Powder inhaler with suction actuated locking means |
US5243970A (en) * | 1991-04-15 | 1993-09-14 | Schering Corporation | Dosing device for administering metered amounts of powdered medicaments to patients |
EP0518087A1 (en) * | 1991-06-14 | 1992-12-16 | Miat S.P.A. | Multi-dose insufflator for medicaments in powder form |
WO1993009832A1 (en) * | 1991-11-12 | 1993-05-27 | Minnesota Mining And Manufacturing Company | Inhalation device |
US5469843A (en) * | 1991-11-12 | 1995-11-28 | Minnesota Mining And Manufacturing Company | Inhalation device |
US5301666A (en) * | 1991-12-14 | 1994-04-12 | Asta Medica Aktiengesellschaft | Powder inhaler |
US5549101A (en) * | 1992-05-05 | 1996-08-27 | Astra Aktiebolag | Dosage inhalator with indicating/interrupting means |
AU669708B2 (en) * | 1992-05-05 | 1996-06-20 | Astra Aktiebolag | Dosage inhalator with indicating/interrupting means |
WO1993021980A1 (en) * | 1992-05-05 | 1993-11-11 | Astra Aktiebolag | Dosage inhalator with indicating/interrupting means |
US5394868A (en) * | 1992-06-25 | 1995-03-07 | Schering Corporation | Inhalation device for powdered medicaments |
US5687710A (en) * | 1992-12-18 | 1997-11-18 | Schering Corporation | Inhaler for powdered medications having spiral deagglomeration chamber |
US5740792A (en) * | 1992-12-18 | 1998-04-21 | Schering Corporation | Inhaler for powdered medications with gear-teeth counter assembly |
US5829434A (en) * | 1992-12-18 | 1998-11-03 | Schering Corporation | Inhaler for powdered medications |
US5441060A (en) * | 1993-02-08 | 1995-08-15 | Duke University | Dry powder delivery system |
US5437271A (en) * | 1993-04-06 | 1995-08-01 | Minnesota Mining And Manufacturing Company | Deagglomerators for dry powder inhalers |
US5533502A (en) * | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
US5975076A (en) * | 1993-12-31 | 1999-11-02 | King's College London | Dry powder inhalers |
WO1995029723A1 (en) * | 1994-05-03 | 1995-11-09 | Transcoject Marketing Gmbh | Inhaler |
US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US6387394B1 (en) | 1995-04-07 | 2002-05-14 | Penwest Pharmaceuticals Co. | Controlled release insufflation carrier for medicaments |
US5738865A (en) * | 1995-04-07 | 1998-04-14 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US7172766B2 (en) | 1995-04-07 | 2007-02-06 | Penwest Pharmaceuticals Company | Controlled release insufflation carrier for medicaments |
EP1283036B1 (en) * | 1998-11-13 | 2008-01-02 | Jagotec AG | Multidosis dry powder inhaler with powder reservoir |
US7207330B1 (en) | 1999-06-05 | 2007-04-24 | Innovata Biomed Limited | Delivery system |
US10588895B2 (en) | 1999-07-14 | 2020-03-17 | Almirall, S.A. | Quinuclidine derivatives and medicinal compositions containing the same |
USRE46417E1 (en) | 1999-07-14 | 2017-05-30 | Almirall, S.A. | Quinuclidine derivatives and their use as muscarinic M3 receptor ligands |
US9687478B2 (en) | 1999-07-14 | 2017-06-27 | Almirall, S.A. | Quinuclidine derivatives and medicinal compositions containing the same |
US10034867B2 (en) | 1999-07-14 | 2018-07-31 | Almirall, S.A. | Quinuclidine derivatives and medicinal compositions containing the same |
US8205614B2 (en) | 1999-09-04 | 2012-06-26 | Innovata Biomed Limited | Delivery device |
US7219665B1 (en) | 1999-09-04 | 2007-05-22 | Innovata Biomed Limited | Delivery device |
US7571724B2 (en) | 1999-09-04 | 2009-08-11 | Innovata Biomed Limited | Delivery device |
US7571723B2 (en) | 1999-09-04 | 2009-08-11 | Innovata Biomed Limited | Delivery device |
EP1941868A2 (en) | 2000-02-28 | 2008-07-09 | PharmaKodex Limited | Improvements in or relating to the delivery of oral drugs |
EP1291031A4 (en) * | 2000-06-12 | 2004-12-15 | Teijin Ltd | Powder medicine multiple dose administration device |
EP1291031A1 (en) * | 2000-06-12 | 2003-03-12 | Teijin Limited | Powder medicine multiple dose administration device |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
US7464704B2 (en) | 2001-11-23 | 2008-12-16 | Innovata Biomed Limited | Medicament delivery assembly |
US8800550B2 (en) | 2001-11-23 | 2014-08-12 | Innovata Biomed Limited | Medicament delivery assembly |
US7617822B2 (en) | 2003-06-16 | 2009-11-17 | Rijksuniversiteit Groningen | Dry powder inhaler and method for pulmonary inhalation of dry powder |
US8851069B2 (en) | 2004-04-21 | 2014-10-07 | Innovata Biomed Limited | Inhaler |
US8511302B2 (en) | 2004-04-24 | 2013-08-20 | Innovata Biomed Limited | Dose counter mechanisms for medicament delivery devices |
EP2319538A2 (en) | 2004-05-31 | 2011-05-11 | Almirall S.A. | Combinations combrising antimuscarinic agents and corticosteroids |
EP2002843A2 (en) | 2004-05-31 | 2008-12-17 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
EP1891974A1 (en) | 2004-05-31 | 2008-02-27 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and PDE4 inhibitors |
EP2002845A2 (en) | 2004-05-31 | 2008-12-17 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and corticosteroids |
EP2138188A1 (en) | 2004-05-31 | 2009-12-30 | Almirall, S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
EP2774622A1 (en) | 2004-05-31 | 2014-09-10 | Almirall, S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
EP1891973A1 (en) | 2004-05-31 | 2008-02-27 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and PDE4 inhibitors |
EP2292267A2 (en) | 2004-05-31 | 2011-03-09 | Almirall S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
EP1905451A1 (en) | 2004-05-31 | 2008-04-02 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and corticosteroids |
EP2002844A2 (en) | 2004-05-31 | 2008-12-17 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarininc agents and beta-adrenergic agonists |
EP2774623A1 (en) | 2004-05-31 | 2014-09-10 | Almirall S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
US8420669B2 (en) | 2005-05-20 | 2013-04-16 | Laboratories Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor |
US7964615B2 (en) | 2005-05-20 | 2011-06-21 | Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor |
EP2263998A1 (en) | 2005-05-20 | 2010-12-22 | Almirall S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
US8242177B2 (en) | 2005-05-20 | 2012-08-14 | Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor |
US8283342B2 (en) | 2007-02-09 | 2012-10-09 | Almirall S.A. | Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor |
WO2008107125A1 (en) | 2007-03-02 | 2008-09-12 | Almirall, S.A. | New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives |
US8178679B2 (en) | 2007-11-28 | 2012-05-15 | Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors |
EP2096105A1 (en) | 2008-02-28 | 2009-09-02 | Laboratorios Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor |
EP2954889A1 (en) | 2008-03-13 | 2015-12-16 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2946768A1 (en) | 2008-03-13 | 2015-11-25 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2946769A1 (en) | 2008-03-13 | 2015-11-25 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2954890A1 (en) | 2008-03-13 | 2015-12-16 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2954891A1 (en) | 2008-03-13 | 2015-12-16 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma |
US11000517B2 (en) | 2008-03-13 | 2021-05-11 | Almirall, S.A. | Dosage and formulation |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
US10085974B2 (en) | 2008-03-13 | 2018-10-02 | Almirall, S.A. | Dosage and formulation |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2108641A1 (en) | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
EP2113503A1 (en) | 2008-04-28 | 2009-11-04 | Laboratorios Almirall, S.A. | New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors |
EP2196465A1 (en) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors |
US8563731B2 (en) | 2008-12-22 | 2013-10-22 | Almirall, S.A. | Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor |
WO2010072354A1 (en) | 2008-12-22 | 2010-07-01 | Almirall, S.A. | MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR |
EP2221297A1 (en) | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases |
EP2221055A1 (en) | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function |
WO2010094483A1 (en) | 2009-02-18 | 2010-08-26 | Almirall, S.A. | 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) -8-hydroxyquinolin-2 (ih)-one for the treatment of lung function |
WO2010094484A1 (en) | 2009-02-18 | 2010-08-26 | Almirall, S.A. | 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino}-l-hydroxyethyl) -8-hydroxyquin olin-2 (1h)-one and its use in the treatment of pulmonary diseases |
WO2010097172A1 (en) | 2009-02-27 | 2010-09-02 | Almirall, S.A. | New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives |
EP2226323A1 (en) | 2009-02-27 | 2010-09-08 | Almirall, S.A. | New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives |
US8524908B2 (en) | 2009-03-12 | 2013-09-03 | Almirall, S.A. | Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
EP2322176A1 (en) | 2009-11-11 | 2011-05-18 | Almirall, S.A. | New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives |
WO2011057757A1 (en) | 2009-11-11 | 2011-05-19 | Almirall, S.A. | New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one derivatives |
EP2380890A1 (en) | 2010-04-23 | 2011-10-26 | Almirall, S.A. | New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors |
EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
WO2011141180A1 (en) | 2010-05-13 | 2011-11-17 | Almirall, S.A. | NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
EP2394998A1 (en) | 2010-05-31 | 2011-12-14 | Almirall, S.A. | 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors |
WO2012041476A1 (en) | 2010-09-30 | 2012-04-05 | Almirall, S.A. | Pyridine and isoquinoline derivatives as syk- and jak-kinase inhibitors |
EP2441755A1 (en) | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
WO2012069175A1 (en) | 2010-11-25 | 2012-05-31 | Almirall, S.A. | New pyrazole derivatives having crth2 antagonistic behaviour |
EP2463289A1 (en) | 2010-11-26 | 2012-06-13 | Almirall, S.A. | Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors |
WO2012069202A1 (en) | 2010-11-26 | 2012-05-31 | Almirall,S.A. | Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors |
EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
US9737520B2 (en) | 2011-04-15 | 2017-08-22 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
WO2012146667A1 (en) | 2011-04-29 | 2012-11-01 | Almirall, S.A. | Imidazopyridine derivatives as pi3k inhibitors |
EP2518070A1 (en) | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Pyrrolotriazinone derivatives as PI3K inhibitors |
EP2518071A1 (en) | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Imidazopyridine derivatives as PI3K inhibitors |
EP2526945A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | New CRTH2 Antagonists |
EP2527344A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
WO2012160030A1 (en) | 2011-05-25 | 2012-11-29 | Almirall, S.A. | Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
EP2548876A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists |
EP2548863A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists. |
WO2013010881A1 (en) | 2011-07-18 | 2013-01-24 | Almirall, S.A. | NEW CRTh2 ANTAGONISTS |
WO2013010880A1 (en) | 2011-07-18 | 2013-01-24 | Almirall, S.A. | New crth2 antagonists |
WO2013017461A1 (en) | 2011-08-01 | 2013-02-07 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
EP2554544A1 (en) | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
US9108918B2 (en) | 2011-10-07 | 2015-08-18 | Almirall, S.A. | Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
EP2592077A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
WO2013068554A1 (en) | 2011-11-11 | 2013-05-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities |
WO2013068552A1 (en) | 2011-11-11 | 2013-05-16 | Almirall, S.A. | NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
WO2013139712A1 (en) | 2012-03-20 | 2013-09-26 | Almirall, S.A. | NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR. |
US9346759B2 (en) | 2012-03-20 | 2016-05-24 | Almirall, S.A. | Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor |
WO2013149959A1 (en) | 2012-04-02 | 2013-10-10 | Almirall, S.A. | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one |
EP2647627A1 (en) | 2012-04-02 | 2013-10-09 | Almirall, S.A. | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one. |
WO2013175013A1 (en) | 2012-05-25 | 2013-11-28 | Almirall, S.A. | Novel dosage and formulation |
EP2666465A1 (en) | 2012-05-25 | 2013-11-27 | Almirall, S.A. | Novel dosage and formulation |
WO2013178742A1 (en) | 2012-05-31 | 2013-12-05 | Almirall, S.A. | Novel dosage form and formulation of abediterol |
EP2668941A1 (en) | 2012-05-31 | 2013-12-04 | Almirall, S.A. | Novel dosage form and formulation of abediterol |
WO2014060431A1 (en) | 2012-10-16 | 2014-04-24 | Almirall, S.A. | Pyrrolotriazinone derivatives as pi3k inhibitors |
EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
WO2014095920A1 (en) | 2012-12-18 | 2014-06-26 | Almirall, S.A. | New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity |
WO2014124757A1 (en) | 2013-02-15 | 2014-08-21 | Almirall, S.A. | Pyrrolotriazine derivatives as pi3k inhibitors |
EP2848615A1 (en) | 2013-07-03 | 2015-03-18 | Almirall, S.A. | New pyrazole derivatives as CRAC channel modulators |
WO2015091285A1 (en) | 2013-12-19 | 2015-06-25 | Almirall S.A. | Dosage formulation comprising salmeterol and fluticasone propionate |
WO2015091287A1 (en) | 2013-12-19 | 2015-06-25 | Almirall S.A. | Dosage formulation comprising salmeterol and fluticasone propionate |
WO2016170009A1 (en) | 2015-04-21 | 2016-10-27 | Almirall, S.A. | Amino-substituted heterocyclic derivatives as sodium channel inhibitors |
WO2016180753A1 (en) * | 2015-05-08 | 2016-11-17 | Iconovo Ab | Dry powder inhaler |
US11000652B2 (en) | 2015-05-08 | 2021-05-11 | Iconovo Ab | Dry powder inhaler |
WO2016202800A1 (en) | 2015-06-16 | 2016-12-22 | Almirall, S.A. | Pyrrolotriazinone derivatives as pi3k inhibitors |
WO2017076990A1 (en) | 2015-11-05 | 2017-05-11 | Almirall, S.A. | Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide |
WO2019030298A1 (en) | 2017-08-08 | 2019-02-14 | Almirall, S.A. | Novel compounds activating the nrf2 pathway |
WO2019066702A1 (en) | 2017-09-28 | 2019-04-04 | Iconovo Ab | A dry powder inhaler with means for enhancing dispersion |
EP3687608A4 (en) * | 2017-09-28 | 2021-06-16 | Iconovo AB | Dry powder inhaler with means for enhancing dispersion |
Also Published As
Publication number | Publication date |
---|---|
FR2447725B3 (en) | 1981-01-02 |
ES248348U (en) | 1980-05-01 |
GB2041763B (en) | 1983-08-17 |
DE8002702U1 (en) | 1980-05-29 |
FR2447725A3 (en) | 1980-08-29 |
ES248348Y (en) | 1981-02-16 |
IT7920688V0 (en) | 1979-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2041763A (en) | An inhalor for pulverulent medicinal substances | |
US5351683A (en) | Device for the administration of powdered medicinal substances | |
EP0518087B1 (en) | Multi-dose insufflator for medicaments in powder form | |
US5794613A (en) | Multiple-dose dispenser for dry powder inhalers | |
EP0333334B1 (en) | Dispensers for powdered medication | |
FI64509C (en) | ANORDNING FOER INHALERING AV CEILINGS | |
JP4044620B2 (en) | System for administration by inhalation of powdered drugs | |
EP0525720B1 (en) | Inhalation devices | |
US5048514A (en) | Inhaler for medicaments contained in capsules | |
KR100399161B1 (en) | Closing caps and methods for filling containers without generating air bubbles | |
US5301666A (en) | Powder inhaler | |
US3844284A (en) | Disposable douche | |
NO145709B (en) | INHALATOR WITH AT LEAST TWO MOVING PARTS FOR DELIVERY OF POWDER-MOLD MEDICINES | |
GB2165159A (en) | Dosing device | |
JPH05200100A (en) | Pack for dosing medicine to patient | |
HU225186B1 (en) | Powder-purifying device and process | |
BG60308B2 (en) | Inhalator | |
HU219117B (en) | A device | |
US4185740A (en) | Disposable capsules | |
EP1173242B1 (en) | Powder inhaler | |
UA62916C2 (en) | Cartridge for pharmaceutical powder intended for powder inhalers and inhaler for powdered drugs | |
EP0519000A1 (en) | Medicament inhalation device. | |
JP2532935Y2 (en) | Dispensing cap | |
US2732104A (en) | de baun | |
CN209351875U (en) | A kind of container holding face pack of Chinese herbal medicine powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19930130 |